The common plasma proteins that were higher in the COVID-19 patients than controls and that were higher in the late recovery group than the early recovery group for phases 1 and 2 were WFDC2, CHI3L1, GDF15, KRT19, and TNFRSF10B (Fig. 2D). The gene discussed is WFDC2; the disease is COVID-19.